Long-Term Overall Survival and Toxicities of ABVD vs BEACOPP in Advanced Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Overall Survival and Toxicities of ABVD vs BEACOPP in Advanced Hodgkin Lymphoma: A Pooled Analysis of Four Randomized Trials
Cancer Med 2020 Jul 25;[EPub Ahead of Print], MPE André, P Carde, S Viviani, M Bellei, C Fortpied, M Hutchings, AM Gianni, P Brice, O Casasnovas, PG Gobbi, PL Zinzani, J Dupuis, E Iannitto, A Rambaldi, J Brière, L Clément-Filliatre, M Heczko, P Valagussa, J Douxfils, J Depaus, M Federico, N MounierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.